Recombinant human interleukin-11 (China Resources Angde Biotech Pharma)

重组人白介素-11衍生物(华润昂德生物药业)

Report date: 2026/05/27 14:26:50

Base Information

Drug NameRecombinant human interleukin-11 (China Resources Angde Biotech Pharma)
Drug Alias Name百杰依
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionThrombopoiesis stimulantsInterleukin 11 receptor alpha stimulants
TargetsInterleukin 11 receptor alpha
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusN/A
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A